PARNAX LAB Latest Share Price (PARNAXLAB)
TODAY IN ONE LINE
PARNAXLAB rose 2.7%, outperforming Nifty's 0.0% move, supported by recent strong earnings.
it trades at a P/E of N/A. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
PARNAX LAB flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●High Promoter HoldingPromoters hold 72.3% skin-in-the-game
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.00x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
No red flags identified
Latest PARNAX LAB News
What changed recently?
Recent events, corporate actions, and announcements.
PARNAX LAB valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for PARNAX LAB, framed against the sector median so the premium or discount is obvious at a glance.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
PARNAX LAB technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for PARNAX LAB — derived from the latest tape, not yesterday's close.
PARNAX LAB last traded at ₹123.49 with an intraday range of ₹121–₹124 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹123.49| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 130.66 | +7.17 | +5.81% |
| R3 | 127.66 | +4.17 | +3.38% |
| R2 | 125.83 | +2.34 | +1.89% |
| R1 | 124.66 | +1.17 | +0.95% |
| PIVOT | 122.83 | -0.66 | -0.53% |
| CURRENT | 123.49 | — | — |
| S1 | 121.66 | -1.83 | -1.48% |
| S2 | 119.83 | -3.66 | -2.96% |
| S3 | 118.66 | -4.83 | -3.91% |
| S4 | 115.66 | -7.83 | -6.34% |
PARNAXLAB is trading Above CPR, indicating Bullishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹117.05–₹123.9
Trading Inside opening range
PARNAX LAB financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for PARNAX LAB — consolidated or standalone — with margins, YoY growth and key ratios inline.
PARNAX LAB reports its full P&L, balance sheet, cash flow and ratios on this page — current reported EPS of ₹0.37.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 188 | 249 ▲ 32.4% |
| Sales Growth YoY %Derived | -0.52% | 32.39% |
| Other Income | 2 | 4 ▲ 125.5% |
| Total Income | 189 | 252 ▲ 33.2% |
| 96 | 147 ▲ 53.2% | |
| Gross ProfitDerived | 92 | 101 ▲ 10.6% |
| Gross Margin %Derived | 48.86% | 40.82% |
| 65 | 74 ▲ 14.2% | |
| EBITDA (Operating Profit)Derived | 27 | 27 ▲ 1.8% |
| OPM %Derived | 14.26% | 10.96% |
| 13 | 12 ▼ 3.0% | |
| Profit Before Tax (PBT) | 16 | 16 ▲ 1.5% |
| 4 | 4 ▼ 0.6% | |
| Effective Tax %Derived | 26.38% | 25.83% |
| Total Profit for Period | 12 | 12 ▲ 2.2% |
| Less: Non-controlling Interests | 0 | 0 ▲ 7.4% |
| Net Profit (Owner's PAT)Derived | 12 | 12 ▲ 2.2% |
| Net Profit Margin %Derived | 6.14% | 4.74% |
| PAT Growth YoY %Derived | 24.14% | 2.24% |
| Earnings Per Share (EPS ₹) | 10.03 | 10.25 ▲ 2.2% |
| Diluted Shares Outstanding (Cr) | 1 | 1 ▲ 0.0% |
| Other Comprehensive Income (Net of Tax) | 0 | 0 ▲ 3315.8% |
| Total Expenses (incl. D&A & Interest) | 174 | 236 ▲ 36.1% |
| Material Cost % of RevenueDerived | 49.99% | 59.84% |
| Employee Cost % of RevenueDerived | 13.01% | 10.92% |
| Other Cost % of RevenueDerived | 21.60% | 18.94% |
| Interest Coverage (x)Derived | 3.60x | 3.36x |
| Period | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 109 | 95 ▼ 12.4% | 90 ▼ 6.1% | 163 ▲ 82.1% | 168 ▲ 2.8% | 189 ▲ 12.6% | 188 ▼ 0.5% | 249 ▲ 32.4% | |
| Sales Growth YoY %Derived | — | -12.38% | -6.08% | 82.12% | 2.81% | 12.59% | -0.52% | 32.39% | |
| Other Income | 2 | 1 ▼ 68.6% | 0 ▼ 68.2% | 0 ▲ 56.8% | 1 ▲ 134.2% | 1 ▲ 5.6% | 2 ▲ 105.5% | 4 ▲ 125.5% | |
| Total Income | 111 | 96 ▼ 13.4% | 90 ▼ 6.5% | 163 ▲ 82.1% | 168 ▲ 3.1% | 190 ▲ 12.6% | 189 ▼ 0.1% | 252 ▲ 33.2% | |
53 | 45 ▼ 14.1% | 41 ▼ 9.0% | 90 ▲ 117.5% | 89 ▼ 0.9% | 103 ▲ 15.8% | 96 ▼ 6.6% | 147 ▲ 53.2% | ||
| Gross ProfitDerived | 56 | 50 ▼ 10.7% | 48 ▼ 3.5% | 73 ▲ 51.9% | 79 ▲ 7.4% | 86 ▲ 9.0% | 92 ▲ 6.8% | 101 ▲ 10.6% | |
| Gross Margin %Derived | 51.54% | 52.50% | 53.96% | 45.01% | 47.01% | 45.52% | 48.86% | 40.82% | |
46 | 44 ▼ 4.9% | 38 ▼ 12.1% | 50 ▲ 31.3% | 56 ▲ 10.8% | 62 ▲ 11.7% | 65 ▲ 4.2% | 74 ▲ 14.2% | ||
| EBITDA (Operating Profit)Derived | 10 | 6 ▼ 37.1% | 10 ▲ 54.7% | 23 ▲ 131.5% | 23 ▼ 0.2% | 24 ▲ 2.4% | 27 ▲ 13.7% | 27 ▲ 1.8% | |
| OPM %Derived | 9.40% | 6.75% | 11.11% | 14.13% | 13.72% | 12.48% | 14.26% | 10.96% | |
8 | 9 ▲ 17.5% | 10 ▲ 13.0% | 11 ▲ 8.3% | 11 ▲ 3.5% | 12 ▲ 7.2% | 13 ▲ 3.7% | 12 ▼ 3.0% | ||
| Profit Before Tax (PBT) | 5 | -2 ▼ 142.6% | -0 ▲ 95.7% | 12 ▲ 14735.1% | 12 ▲ 0.1% | 12 ▼ 1.9% | 16 ▲ 30.1% | 16 ▲ 1.5% | |
1 | 1 ▼ 27.8% | 0 ▼ 70.8% | 4 ▲ 1346.7% | 4 ▼ 4.2% | 3 ▼ 28.2% | 4 ▲ 50.1% | 4 ▼ 0.6% | ||
| Effective Tax %Derived | 28.45% | -48.23% | -330.43% | 32.66% | 31.25% | 22.87% | 26.38% | 25.83% | |
| Total Profit for Period | 3 | -3 ▼ 188.2% | -0 ▲ 87.6% | 8 ▲ 2389.5% | 9 ▲ 4.5% | 9 ▲ 7.7% | 12 ▲ 24.2% | 12 ▲ 2.2% | |
| Less: Non-controlling Interests | 0 | -0 ▼ 127.3% | 0 ▲ 183.3% | 0 ▲ 926.7% | 0 ▼ 3.2% | 0 ▲ 4.7% | 0 ▲ 30.1% | 0 ▲ 7.4% | |
| Net Profit (Owner's PAT)Derived | 3 | -3 ▼ 188.3% | -0 ▲ 87.6% | 8 ▲ 2375.8% | 9 ▲ 4.6% | 9 ▲ 7.7% | 12 ▲ 24.1% | 12 ▲ 2.2% | |
| Net Profit Margin %Derived | 3.03% | -3.06% | -0.40% | 5.06% | 5.14% | 4.92% | 6.14% | 4.74% | |
| PAT Growth YoY %Derived | — | -188.34% | 87.57% | 2,375.76% | 4.55% | 7.67% | 24.14% | 2.24% | |
| Earnings Per Share (EPS ₹) | 3.88 | -3.43 ▼ 188.4% | -0.43 ▲ 87.5% | 8.40 ▲ 2053.5% | 7.50 ▼ 10.7% | 8.37 ▲ 11.6% | 10.03 ▲ 19.8% | 10.25 ▲ 2.2% | |
| Diluted Shares Outstanding (Cr) | 1 | 1 ▲ 0.0% | 1 ▲ 0.0% | 1 ▲ 15.4% | 1 ▲ 17.0% | 1 ▲ 0.0% | 1 ▲ 0.0% | 1 ▲ 0.0% | |
| Other Comprehensive Income (Net of Tax) | -0 | -0 ▲ 73.5% | 0 ▲ 632.1% | -0 ▼ 202.6% | -0 ▲ 12.4% | -0 ▼ 88.4% | 0 ▲ 104.0% | 0 ▲ 3315.8% | |
| Total Expenses (incl. D&A & Interest) | 106 | 98 ▼ 7.8% | 90 ▼ 8.3% | 151 ▲ 68.2% | 156 ▲ 3.3% | 177 ▲ 13.7% | 174 ▼ 2.1% | 236 ▲ 36.1% | |
| Material Cost % of RevenueDerived | 40.37% | 47.52% | 45.14% | 55.90% | 52.75% | 55.50% | 49.99% | 59.84% | |
| Employee Cost % of RevenueDerived | 12.01% | 14.77% | 15.29% | 10.69% | 11.96% | 12.57% | 13.01% | 10.92% | |
| Other Cost % of RevenueDerived | 30.14% | 30.98% | 27.56% | 20.20% | 21.33% | 20.47% | 21.60% | 18.94% | |
| Interest Coverage (x)Derived | 1.65x | 0.43x | 0.94x | 3.28x | 3.32x | 3.10x | 3.60x | 3.36x |
PARNAX LAB segment analysis : revenue and profit mix.
Disclosed business segments at PARNAX LAB with their share of revenue and profit, switchable between consolidated and standalone reporting.
PARNAX LAB discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for PARNAX LAB.
Our AI distills the core fundamental drivers supporting PARNAX LAB, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
What you're getting.
No strengths or opportunities on record.
Key Risks.
No weaknesses or threats on record.
Flip Conditions.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
PARNAX LAB peer comparison — same-sector benchmarks.
No comparable peer set was disclosed for PARNAX LAB.
Peer comparison data is not available.
PARNAX LAB chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for PARNAX LAB — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
PARNAX LAB delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for PARNAX LAB over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in PARNAX LAB stood at 92.9% of traded volume, against a 20-day average of 81.0%.
PARNAX LAB announcements: results, concalls, ratings, M&A.
Filings PARNAX LAB sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
PARNAX LAB files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 23 documents below.
Company Update
Please find enclosed herewith the Newspaper Advertisement regarding AGM Notice for the year ended March 31, 2026.
AGM/EGM
Please find enclosed herewith the Notice of the 44th AGM of the Company.
Others
Please find enclosed herewith the Annual Report for the year ended March 31, 2026.
Corp. Action
Please find enclosed herewith the Notice of Book Closure for the purpose of 44th AGM of the Company to be held on 29th September, 2026.
PARNAX LAB dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue PARNAX LAB has declared, sequenced by announce and record date.
PARNAX LAB corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About PARNAX LAB: business, sector, key facts.
What PARNAX LAB does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
PARNAX LAB is a listed Indian equity.
PARNAX LAB
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
Questions investors ask about PARNAX LAB (PARNAXLAB).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of PARNAX LAB (PARNAXLAB)?
The current share price of PARNAX LAB (PARNAXLAB) is ₹123.49. Today, the stock has gained by ₹3.23 (2.69%), trading in a range of ₹121.00 to ₹124.00. The stock opened at ₹121.00 with a trading volume of 710 shares.
02What is the 52-week high and low price of PARNAX LAB stock?
The 52-week high price of PARNAX LAB (PARNAXLAB) is ₹149.50, while the 52-week low is ₹104.00. Currently trading at ₹123.49, the stock is 18.74% above its 52-week low and 17.4% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
03What is the dividend yield of PARNAX LAB and when is the next dividend?
PARNAX LAB offers a dividend yield of 0%, which means for every ₹100 invested at the current price of ₹123.49, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
04How is PARNAX LAB stock performing today in the market?
PARNAX LAB stock opened at ₹121.00 and is currently trading at ₹123.49, showing a gain of ₹3.23 (2.69%). The intraday high is ₹124.00 and low is ₹121.00. The trading volume stands at 710 shares, indicating moderate market participation today.
05What is the market capitalization of PARNAX LAB?
PARNAX LAB has a market capitalization of ₹0, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹123.49) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
06What is the ROE and ROCE of PARNAX LAB?
PARNAX LAB has a Return on Equity (ROE) of 0% and Return on Capital Employed (ROCE) of 0%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
07Which sector and industry does PARNAX LAB belong to?
PARNAX LAB operates in the broader sector and belongs to the its industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
08What is the sales and profit growth of PARNAX LAB?
PARNAX LAB has reported a sales growth of 0% and profit growth of -49.73%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
The data, ratios and commentary about PARNAX LAB (PARNAXLAB) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.